Overview A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-348(6) Status: Completed Trial end date: 2024-03-18 Target enrollment: Participant gender: Summary A phase I clinical trial to evaluate the tolerability and the pharmacokinetics of CKD-348(6). Phase: Phase 1 Details Lead Sponsor: Chong Kun Dang Pharmaceutical